Business Context and Reporting Period
Company: Intelligent Bio Solutions Inc. (INBS)
Filing Type: Form 8-K (Current Report)
Date of Report: October 16, 2025
Event: Annual Meeting of Stockholders held on October 16, 2025, in a virtual-only format.
Key Financial Metrics
This filing is a Current Report regarding corporate governance and stockholder actions. It does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data.
Material Changes and Voting Results
Stockholders approved several key proposals at the Annual Meeting. The total shares voted were 4,482,941, representing approximately 49.65% of the 9,028,712 shares outstanding as of the record date (September 11, 2025).
- Director Elections: All four nominees (Stephen Boyages, Jonathan Hurd, Jason Isenberg, Nicola Fraser) were elected.
- Independent Auditor: Ratified the appointment of UHY LLP for the fiscal year ending June 30, 2026.
- Equity Incentive Plan Amendment: Approved an increase of 495,000 shares to the 2019 Long Term Incentive Plan, raising the total authorized shares from 1,300,000 to 1,795,000.
- Warrant Exercise: Approved the issuance of up to 4,147,616 shares upon warrant exercise to comply with Nasdaq Listing Rule 5635(d).
- Reverse Stock Split Authorization: Approved an amendment to the Certificate of Incorporation authorizing a reverse stock split (ratio between 1-for-2 and 1-for-10) if necessary to regain compliance with Nasdaq minimum bid price requirements within 12 months.
- Adjournment Authority: Approved authority to adjourn the meeting to solicit additional proxies if necessary for the Warrant Exercise or Reverse Stock Split proposals.
Guidance, Outlook, and Risks
The filing does not provide forward-looking financial guidance or management commentary on operational outlook. However, the approval of the Reverse Stock Split Proposal indicates a material risk regarding the company's current compliance with Nasdaq Capital Market minimum bid price requirements.
Investor Verification Checklist
- Verify the current trading price of INBS to assess the immediate necessity of the authorized reverse stock split.
- Review the definitive Proxy Statement (Schedule 14A) filed on September 19, 2025, for detailed terms of the 2019 Plan Amendment and warrant exercise conditions.
- Monitor future board announcements regarding the specific ratio and timing of any potential reverse stock split.
- Check the company's next periodic report (10-Q or 10-K) for updated financial metrics and liquidity status.